Science and technology for wealth and health in developing countries

Global Public Health

Volumn 2, Issue 1, 2007, Pages 53-63

  Acharya, T ^a  

^a Rockefeller and Gates Foundations ^*

Author keywords

Developing countries; Global health; Science; Technology

Indexed keywords

RECOMBINANT VACCINE;

ARTICLE; BRAZIL; CHINA; COST CONTROL; DEVELOPING COUNTRY; DRUG DEVELOPMENT; ENVIRONMENTAL SANITATION; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INDIA; INDUSTRIALIZATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SOCIOECONOMICS; TRAINING; WATER SUPPLY;

BUDGETS; DEVELOPING COUNTRIES; FINANCIAL SUPPORT; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INDUSTRY; INVESTMENTS; POLICY MAKING; PUBLIC HEALTH; PUBLIC POLICY; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; SCIENCE; SOCIAL CHANGE; TECHNOLOGY; TECHNOLOGY TRANSFER; WORLD HEALTH;

EID: 34248585388     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441690600673833     Document Type: Article

References (32)

1. Acharya, T., Daar, A.S. and Singer, P.A. (2003) Biotechnology and the UN's Millennium Development Goals. Nature Biotechnology, 21:12, pp. 1434-1436.
2. Basu, P. (2004) Trading on Traditional Medicines. Nature Biotechnology, 22:3, p. 263.
3. Daar, A.S., Thorsteinsdóttir, H., Martin, D.K., Smith, A.C., Nast, S. and Singer, P.A. (2002) Top Ten Biotechnologies for Improving Health in Developing Countries. Nature Genetics, 32, pp. 229-232.
4. Dasgupta, M. (2005) New Strategy Needed in Vaccine Research.
5. Datta, P.T.J. (2005) Mangalam Drugs Bets on Anti-Malarial Drugs.
6. Estrada, D. (2005) Mapuche Culture a Boon to Health and Palate.
7. Evans, T., Whitehead, M., Ditrichson, F. and Wirth, M. (2001) Challenging Inequities in Health: From Ethics to Action (New York: Oxford University Press), pp. 76-89.
8. Galambos, L. and Sewell, J.E. (1997) Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995, Cambridge University Press
9. (2005) News Tuberculosis: South African, Indian Drug Makers Form Partnership To Produce TB Products.
10. Goldemberg, J. (1998) What is the Role of Science in Developing Countries?. Science, 279:5354, pp. 1140-1141.
11. Gopalakrishnan, R. (2004) Venture Finance Not In SSIs' Radar.
12. Jayaraman, K.S. (2005) Biotech Boom. Nature Biotechnology, 436, pp. 480-484.
13. Juma, C. (2005) We Need to Reinvent the African University.
14. Juma, C. and Lee, Y-C. (2005) Reinventing Global Health: The Role of Science, Technology, and Innovation. The Lancet, 365
15. Lambo, E. (2005) Achieving the Health Millennium Development Goals in Sub-Saharan Africa: The Role of Science and Technology.
16. Leighton, P. (2005) US$21 Million for Innovative Technologies in Chile.
17. (2005) Universities in Shantou, Xiamen and Hong Kong develop rapid diagnostic tests for H5N1 bird flu infection.
18. Liu, Y. (2004) China's Public Health-Care System: Facing the Challenges. Bulletin of the World Health Organisation, 82, p. 7.
19. Mandy, W., Janossy, G., Glencross, D., Barnett, D., Mermin, J. and Downing, R. (2002) Less expensive CD4+ T cell monitoring using Panleucogating. Poster presentation at XIV International AIDS Conference.
20. Mani, S. and Bartzokas, A. (2002) Institutional support for investing in new technologies: The role of venture capital in developing countries. United Nations University, Institute for New Technologies
21. Marshall, S.J. (2004) Developing Countries Face Double Burden of Disease. Bulletin of the World Health Organisation, 82:7, p. 556.
22. Moran, M. (2005) Fast Track Options as a Fundraising Mechanism to Support R&D into Neglected Diseases.
23. Morel, C.M., Acharya, T., Broun, D., Dangi, A., Elias, C., Ganguly, N.K., Gardner, C.A., Gupta, R.K., Haycock, J., Heher, A.D., Hotez, P.J., Kettler, H.E., Keusch, G.T., Krattiger, A.F., Kreutz, F.T., Lall, S., Lee, K., Mahoney, R., Martinez-Palomo, A., Mashelkar, R.A., Matlin, S.A., Mzimba, M., Oehler, J., Ridley, R.G., Senanayake, P., Singer, P. and Yun, M. (2005) Health Innovation Networks to Help Developing Countries Address Neglected Diseases. Science, 309:5733, pp. 401-404.
24. Nair, M.D. (2002) The Pharma Policy-2002: The Positives And The Negatives.
25. Over, M., Bakote'e, B., Velayudhan, R., Wilikai, P. and Graves, P.M. (2004) Impregnated Nets or DDT Residual Spraying? Field Effectiveness of Malaria Prevention Techniques in Solomon Islands, 1993-1999. American Journal of Tropical Medicine and Hygiene, 71:2, pp. 214-223.
26. Padma, T.V. (2004) India, Brazil and South Africa Discuss Joint Research, SciDev.net.
27. Prahalad, C.K. (2004) The Fortune at the Bottom of thePyramid-EradicatingPoverty Through Profits, Wharton School Publishing, Philadelphia
28. Snow, R. and White, N. (2004) New Vaccines are not the Only Answer to Malaria. SciDev.net.
29. Szreter (2004) Industrialization and Health. British Medical Bulletin, 69, pp. 75-86.
30. Tang, Y., Dong, Y. and Vennerstrom, J.L. (2004) Synthetic Peroxides as Antimalarials. Med Res Review, 24:4, pp. 425-448.
31. Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R. and Ford, N. (2002) Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure. The Lancet, 22359:9324, pp. 2188-2194.
32. (2005) Innovation: Applying Knowledge in Development